Ab­b­Vie ex­pects $8.7B Cerev­el buy to close ‘as ear­ly as next week,’ new CEO says

Ab­b­Vie said Thurs­day that its high­ly an­tic­i­pat­ed ac­qui­si­tion of Cerev­el Ther­a­peu­tics is slat­ed to close soon. It al­so re­port­ed high­er-than-an­tic­i­pat­ed

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER